About us
We have developed a first-in-class therapeutical approach to tackle some of the world's most intractable diseases.
We are engineering circular RNAs that target structural elements in the RNA that are crucial for the development of disease and combining them with state-of-the-art delivery techniques. Our technology is based on the research from the Molecular Virology Group of Universitat Pompeu Fabra.
Our multidisciplinary team is committed to bring our technology to the hands of those who need it the most, the patients. Throughout this amazing journey, we also count with the support of our excellent Advisory Board.
Team

Miriam Corredor Sánchez
PhD, MBI
Chief Executive Officer

Marc Talló Parra
PhD
Chief Scientific Officer

Ivan Dotu Rodriguez
PhD
VP of Research

Flor Alonso
PhD
Researcher

Mònica Mendoza Blanco
PhD
Researcher

Marta Casas Vilaseca
MSc
Bioinformatician

Judit Tomsen Melero
PhD
Preclinical Project Manager
Advisory Board

Juana Díez Antón
PhD
Scientific Advisor

Miquel Angel Rubio
PhD, MD
Clinical Advisor
